Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-07-24

FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Apotex Corp)

View source ↗

Summary

FDA approved a supplemental ANDA for fluvoxamine maleate from Apotex Corp, enabling generic product availability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)